Business Standard

Tuesday, December 24, 2024 | 11:53 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Risk of hospitalisation doubles with Delta versus Alpha variant: Study

Vaccines from Pfizer Inc. and AstraZeneca Plc protect against delta, researchers said Monday

Photo: Bloomberg
Premium

Photo: Bloomberg

Katharine Gemmell | Bloomberg
People infected with Covid-19’s delta variant, first detected in India, are more than twice as likely to end up in the hospital than with the alpha variant identified in the U.K. last year.

Vaccines from Pfizer Inc. and AstraZeneca Plc protect against delta, researchers said Monday. They found the shot made by Pfizer and partner BioNTech SE offered better protection in a large study from Scotland.

The findings, presented in a research letter published in The Lancet, come as U.K. officials wrestle with whether to delay a lift in pandemic restrictions as the delta variant spreads.

ALSO READ: 

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in